ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Philippe Menasche
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Menasche, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Menasche, P.
Related Collections
Right arrow Molecular biology

Ann Thorac Surg 2007;84:339-342
© 2007 The Society of Thoracic Surgeons

Key References

Cellular Therapy in Thoracic and Cardiovascular Disease

Philippe Menasche, MD, PhD*

Assistance Publique-Hopitaux de Paris, Hôpital Européen Georges Pompidou, Department of Cardiovascular Surgery; University Paris-Descartes, Faculty of Medicine, Paris, France

* Address correspondence to Dr Menasche, Hôpital Européen Georges Pompidou, Department of Cardiovascular Surgery, 20, rue Leblanc, Paris, 75015, France (Email: philippe.menasche@egp.aphp.fr).

The first 300 words of the full text of this article appear below.


   Reviews
 

1 Melo LG, Pachori AS, Kong D, et al. Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium: reasons for cautious optimism. Circulation 2004;109:2386–93.
2 Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. Clin Invest 2005;115:572–83.
3 Murry CE, Field LJ, Menasche P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 2005;112:3174–83.
4 Fazel S, Tang GH, Angoulvant D, et al. Current status of cellular therapy for ischemic heart disease. Ann Thorac Surg 2005;79:S2238–47.
5 Sanchez PL, San Roman JA, Villa A, et al. Contemplating the bright future of stem cell therapy for cardiovascular disease. Nat Clin Pract Cardiovasc Med 2006;(Suppl 1):S138–51.


   Adult Somatic Cells
 
Skeletal Myoblasts
Experimental studies

6 Murry CE, Wiseman RW, Schwartz SM, et al. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 1996;98:2512–23.
7 Taylor DA, Atkins BZ, Hungspreugs P, et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998;4:929–33. Erratum in: Nat Med 1998;4:1200.
8 Reinecke H, Poppa V, Murry CE. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 2002;34:241–9.
9 Suzuki K, Murtuza B, Beauchamp JR, et al. Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J 2004;18:1153–5.
10 Ott HC, Bonaros N, Marksteiner R, et al. Combined transplantation of skeletal myoblasts and bone marrow stem cells for myocardial repair in rats. Eur J Cardio-thorac Surg 2004;25:627–34.
11 Christman KL, Vardanian AJ, Fang Q, et al. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 2004;44:654–60.
12 Maurel A, Azarnoush K, Sabbah L, et al. Can cold or heat shock improve skeletal myoblast engraftment in infarcted myocardium? Transplantation 2005;5;80:660–5.
13 Yau TM, Kim C, Ng D, et . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The Society of Thoracic Surgeons.